US 21 CFR FDA Regulation Part 177.1520
US 21 CFR FDA Regulation Part 177.1520
US 21 CFR FDA Regulation Part 177.1520
SUMMARY: The Food and Drug Administration (FDA) is amending the food additive regulations
to provide for the expanded safe use of ethylene-octene-1 copolymers, containing not less than
50 weight-percent of polymer units derived from ethylene, as articles or components of food-contact
articles. This action is in response to a petition filed by The Dow Chemical Co.
DATES: This rule is effective [insert date of publication in the Federal Register]. Submit written
objections and requests for a hearing by [insert date 30 days after date of publication in the Federal
Register].
ADDRESSES: Submit written objections to the Dockets Management Branch (HFA-305), Food and
FOR FURTHER INFORMATION CONTACT: Julius Smith, Center for Food Safety and Applied Nutrition
(HFS-215), Food and Drug Administration, 200 C St. SW., Washington, DC 20204,202-418-
3091.
SUPPLEMENTARY INFORMATION: In a notice published in the Federal Register of July 28, 1998
(63 FR 40297), FDA announced that a petition (FAP 8B4601) had been filed by The Dow Chemical
Co., 2030 Dow Center, Midland, MI 48674. The petition proposed to amend the food additive
regulations in 5 177.1520 OZejGzpolymers (21 CFR 177.1520) to expand the safe use of ethylene-
rfnn7
2
octene-1 copolymers as articles or components of articles contacting food by lowering the required
FDA has evaluated the data in the petition and other relevant material. Based on this
information, the agency concludes that: (1) The proposed use of the additive is safe, (2) the additive
will achieve its intended technical effect, and therefore, (3) the regulations should be amended
as set forth below.
In accordance with $ 171.1(h) (2 1 CFR 17 1.1(h)), the petition and the documents that FDA
considered and relied upon in reaching its decision to approve the petition are available for
inspection at the Center for Food Safety and Applied Nutrition by appointment with the information
contact person listed above. As provided in 8 171.1(h), the agency will delete from the documents
any materials that are not available for public disclosure before making the documents available
for inspection.
The agency has carefully considered the potential environmental effects of this action. FDA
has concluded that the action will not have a significant impact on the human environment, and
that an environmental impact statement is not required. The agency’s finding of no significant
impact and the evidence supporting that finding, contained in an environmental assessment, may
be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday
through Friday.
This final rule contains no collection of information. Therefore, clearance by the Office of
Management and Budget under the Paperwork Reduction Act of 1995 is not required.
Any person who will be adversely affected by this regulation may at any time file with the
Dockets Management Branch (address above) written objections by [insert date 30 days after date
of publication in the Federal Register]. Each objection shall be separately numbered, and each
numbered objection shall specify with particularity the provisions of the regulation to which
objection is made and the grounds for the objection. Each numbered objection on which a hearing
is requested shall specifically so state. Failure to request a hearing for any particular objection
shall constitute a waiver of the right to a hearing on that objection. Each numbered objection
for which a hearing is requested shall include a detailed description and analysis of the specific
factual information intended to be presented in support of the objection in the event that a hearing
is held. Failure to include such a description and analysis for any particular objection shall constitute
a waiver of the right to a hearing on the objection. Three copies of all documents are to be
submitted and are to be identified with the docket number found in brackets in the heading of
this document. Any objections received in response to the regulation may be seen in the Dockets
Management Branch between 9 a.m. and 4 p.m., Monday through Friday.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated
to the Commissioner of Food and Drugs and redelegated to the Director, Center for Food Safety
1. The authority citation for 2 1 CFR part 177 continues to read as follows:
* * * * *
64 * * *
(3) * * *
(9 * * *
(4 * * *
4
(4) Olefin basic copolymers manufactured by the catalytic polymerization of ethylene and
octene-1 shall contain not less than 50 weight-percent of polymer units derived from ethylene.
* * * * *
03 * * *
Maximum extractable
Melting Poing (MP) Maximum soluble fraction
fraction (expressed as (expressed as percent by
Olefin polymers or softening point percent by weight of the
Density weight of polymer) in xylene
(SP) (D;.e;s Cenri- polymer in N-hexane at
specified temperatures at specified temperatures
. l l . l l
* * * * *
5
cfOO2
Dated:
February 29, 2000
L. Robert Lake
Director t
* of Regulations T Policy
Center for Food Safety and Applied Nutrition